أخبار السوق

تابع أحدث الأخبار المالية والاقتصادية وتحديثات الأسواق والتقارير والتحليلات على PipVero.

المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Why Teradyne (TER) Might be Well Poised for a Surge

Why Teradyne (TER) Might be Well Poised for a Surge

Teradyne (TER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

الرموز ذات الصلة 1
TER TER
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Why Amphenol (APH) Might be Well Poised for a Surge

Why Amphenol (APH) Might be Well Poised for a Surge

Amphenol (APH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

الرموز ذات الصلة 1
APH APH
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Surging Earnings Estimates Signal Upside for Emcor Group (EME) Stock

Surging Earnings Estimates Signal Upside for Emcor Group (EME) Stock

Emcor Group (EME) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

الرموز ذات الصلة 1
EME EME
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Earnings Estimates Rising for RPC (RES): Will It Gain?

Earnings Estimates Rising for RPC (RES): Will It Gain?

RPC (RES) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

الرموز ذات الصلة 1
RES RES
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Earnings Estimates Rising for FormFactor (FORM): Will It Gain?

Earnings Estimates Rising for FormFactor (FORM): Will It Gain?

FormFactor (FORM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

الرموز ذات الصلة 1
FORM FORM
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Can ADTRAN's AI Networking Push Offset Near-Term Execution Risks?

Can ADTRAN's AI Networking Push Offset Near-Term Execution Risks?

ADTN is expanding its AI networking portfolio, but execution issues and margin pressure may delay the payoff from growing AI infrastructure demand.

الرموز ذات الصلة 1
ADTN ADTN
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

RARE beats Q2 earnings estimates as revenues surge year over year to a record quarterly high, driven by higher product sales across its portfolio.

الرموز ذات الصلة 1
RARE RARE
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?

Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?

Plexus is delivering faster growth, higher earnings and wider margins, but premium valuation and weaker near-term cash flow temper the buy case.

الرموز ذات الصلة 1
PLXS PLXS
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Market Watch وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli Lilly outmaneuvered it and took control of the diet-drug market.

الرموز ذات الصلة 1
GLP GLP
المصدر: Market Watch
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
HF Sinclair: In A Sweet Spot If Russian Supply Does Not Return

HF Sinclair: In A Sweet Spot If Russian Supply Does Not Return

HF Sinclair (DINO) is rated Buy, with 50% upside to a $133 price target, driven by sustained tightness in global refined products markets. DINO's diversified model, including midstream and marketing, buffers refining margin volatility; the upcoming lubricants spinoff provides additional upside potential. Consensus forecasts underestimate the duration of elevated crack spreads, assuming rapid normalization, while my base case expects prolonged high margins due to persistent geopolitical disruptions.

الرموز ذات الصلة 1
DINO DINO
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: Proactive Investors وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
SolarEdge forecasts weaker Q3 as US residential market remains challenging

SolarEdge forecasts weaker Q3 as US residential market remains challenging

SolarEdge Technologies (NASDAQ:SEDG) shares fell about 24% on Wednesday after the solar technology company issued a weaker-than-expected third quarter outlook, overshadowing better-than-expected second quarter results. The company guided for Q3 2026 revenue of $310 million to $340 million, with a midpoint of $325 million, below analyst expectations of roughly $368 million to $372 million.

الرموز ذات الصلة 1
SEDG SEDG
المصدر: Proactive Investors
زيارة المصدر
تعليق
المصدر: 24/7 Wall Street وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
The Real Reason Berkshire Sold Every Amazon Share Has Nothing to Do With Amazon

The Real Reason Berkshire Sold Every Amazon Share Has Nothing to Do With Amazon

Berkshire Hathaway finished selling its Amazon (NASDAQ:AMZN | AMZN Price Prediction) position earlier this year in two clean sweeps.

الرموز ذات الصلة 1
المصدر: 24/7 Wall Street
زيارة المصدر
تعليق
المصدر: 24/7 Wall Street وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Last Chance – 5 Dividend Stocks You Must Buy This Week to Get Paid in August

Last Chance – 5 Dividend Stocks You Must Buy This Week to Get Paid in August

Income investors have intriguing opportunities and a narrow decision window this week.

الرموز ذات الصلة 1
ASTE ASTE
المصدر: 24/7 Wall Street
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure on older drugs.

الرموز ذات الصلة 1
AMGN AMGN
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Can MRVL's Communications Recovery Drive Broad-Based Growth?

Can MRVL's Communications Recovery Drive Broad-Based Growth?

Marvell Technology's MRVL communications and other business segment has been recovering as customer inventories normalize. In the first quarter of fiscal 2027, communications and other revenues increased 29% year over year to $585 million.

الرموز ذات الصلة 1
MRVL MRVL
المصدر: Zacks Investment Research
زيارة المصدر
تعليق